Affinity DataKi: 0.0290nMAssay Description:Binding affinity against Rat 5-hydroxytryptamine 7 receptor using [3H]-5-HTMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
Affinity DataKi: 0.100nMAssay Description:Human 5-HT2A Receptor, Human 5-HT7 Receptor, and Human D2 Receptor: Binding affinity of the present compound for human 5-HT2A receptor, human 5-HT7 r...More data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
Affinity DataKi: 0.100nMAssay Description:Displacement of [3H]LSD from human recombinant 5-HT7 receptor expressed in CHO-K1 cell membrane after 120 mins by liquid scintillation counting analy...More data for this Ligand-Target Pair
Affinity DataKi: 0.120nMAssay Description:Binding affinity at rat 5-hydroxytryptamine 7 receptor.More data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
Affinity DataKi: 0.130nMAssay Description:Displacement of [3H]LSD from human 5HT7 receptorMore data for this Ligand-Target Pair
Affinity DataKi: 0.130nM ΔG°: -58.7kJ/molepH: 7.4 T: 2°CAssay Description:IC50 values for each test compound were determined from nonlinear regression analysis of data collected from ligand binding experiments. The inhibiti...More data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
Affinity DataKi: 0.170nMAssay Description:Displacement of [3H]LSD from human recombinant 5-HT7 receptor expressed in CHO cells after 120 mins by scintillation countingMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
Affinity DataKi: 0.200nMAssay Description:Displacement of [3H]LSD from human recombinant 5-HT7 receptor expressed in CHO-K1 cell membrane after 120 mins by liquid scintillation counting analy...More data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
Affinity DataKi: 0.200nMAssay Description:Binding affinity against 5-Hydroxy tryptamine 7 receptorMore data for this Ligand-Target Pair
Affinity DataKi: 0.220nMAssay Description:Displacement of [3H]LSD from rat recombinant 5-HT7 receptor expressed in HEK293 cell membranes incubated for 60 mins by radioligand binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 0.220nMAssay Description:Displacement of [3H]LSD from rat recombinant 5HT7 receptor expressed in HEK293 cellsMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
Affinity DataKi: 0.220nMAssay Description:Displacement of [3H]5-HT from human 5HT7 receptor transfected in CFO-K1 cells after 30 mins by liquid scintillation spectrometryMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
Affinity DataKi: 0.220nMAssay Description:Displacement of [3H]-5-CT from human 5-HT7 receptor expressed in HEK293 cells after 1 hr by beta-countingMore data for this Ligand-Target Pair
Affinity DataKi: 0.220nMAssay Description:Inhibition of recombinant human N-terminal GST-tagged KDM4B (1 to 500 residues) expressed in baculovirus infected sf9 cells using biotin-H3K9me3 as s...More data for this Ligand-Target Pair
Affinity DataKi: 0.220nM ΔG°: -57.3kJ/molepH: 7.4 T: 2°CAssay Description:IC50 values for each test compound were determined from nonlinear regression analysis of data collected from ligand binding experiments. The inhibiti...More data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
Affinity DataKi: 0.220nMAssay Description:Displacement of [3H]-5-CT from human 5HT7 receptor expressed in HEK293 cells after 1 hrMore data for this Ligand-Target Pair
Affinity DataKi: 0.251nMAssay Description:Binding affinity at rat 5-hydroxytryptamine 7 receptor.More data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
Affinity DataKi: 0.260nMAssay Description:Displacement of [3H]LSD from recombinant human 5-HT7 receptor expressed in CHO cell membranes after 120 mins by TopCount scintillation counting metho...More data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
Affinity DataKi: 0.300nMAssay Description:Binding affinity against 5-Hydroxy tryptamine 7 receptorMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
Affinity DataKi: 0.300nMAssay Description:Binding affinity against 5-Hydroxy tryptamine 7 receptorMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
Affinity DataKi: 0.300nMAssay Description:Displacement of [3H]-5-CT from human 5-HT7b receptor expressed in HEK293 cells after 1 hrMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
Affinity DataKi: 0.300nMAssay Description:Displacement of [3H]-5-CT from human cloned 5HT7 receptorMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
Affinity DataKi: 0.300nMAssay Description:Displacement of [3H]5CT from human cloned 5HT7B receptor expressed in HEK293 cellsMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
Affinity DataKi: 0.316nMAssay Description:Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]5-CT as the radioligand (n...More data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
Affinity DataKi: 0.339nMAssay Description:Displacement of [3H]LSD from human 5-HT7 receptor expressed in HEK cell membranes after 1.5 hrs by microbeta scintillation counting methodMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
Affinity DataKi: 0.339nMAssay Description:Displacement of [3H]-LSD from 5HT7 receptor (unknown origin) transfected in HEK293 cells incubated for 1.5 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
Affinity DataKi: 0.339nMAssay Description:Displacement of [3H]LSD from 5-HT7 receptor (unknown origin) expressed in CHO-K1 cells by liquid scintillation counting methodMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
Affinity DataKi: 0.340nMAssay Description:Displacement of [3H]-LSD from 5HT7 receptor (unknown origin) transfected in HEK293 cells incubated for 1.5 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
Affinity DataKi: 0.340nMAssay Description:Displacement of [3H]D-lysergic acid diethylamide from 5HT7R (unknown origin) expressed in HEK293 cell membranes incubated for 1.5 hrs in absence of l...More data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
Affinity DataKi: 0.340nMAssay Description:Displacement of [3H]LSD from 5-HT7 receptor (unknown origin) expressed in CHO-K1 cells by liquid scintillation counting methodMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
Affinity DataKi: 0.340nMAssay Description:Displacement of [3H]LSD from 5-HT7R (unknown origin) expressed in CHO-K1 cells by liquid scintillation counting methodMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
Affinity DataKi: 0.340nMAssay Description:Displacement of [3H]LSD from human 5-HT7 receptor expressed in HEK cell membranes after 1.5 hrs by microbeta scintillation counting methodMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
Affinity DataKi: 0.350nMAssay Description:Displacement of [3H]-5-CT from human 5-HT7R expressed in human HEK293 cells assessed as inhibitory constant incubated for 60 mins by radioligand bind...More data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
Affinity DataKi: 0.380nMAssay Description:Displacement of [3H]LSD from human recombinant 5HT7 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
SUMITOMO DAINIPPON PHARMA CO., LTD.
US Patent
Affinity DataKi: 0.380nMAssay Description:Displacement of [3H]LSD from human recombinant 5HT7 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
